Cargando…
National Institute for the Infectious Diseases “L. Spallanzani”, IRCCS. Recommendations for COVID-19 clinical management
On January 9 2020, the World Health Organization (WHO) declared the identification, by Chinese Health authorities, of a novel coronavirus, further classified as SARS-CoV-2 responsible of a disease (COVID-19) ranging from asymptomatic cases to severe respiratory involvement. On March 9 2020, WHO decl...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PAGEPress Publications, Pavia, Italy
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7097833/ https://www.ncbi.nlm.nih.gov/pubmed/32218915 http://dx.doi.org/10.4081/idr.2020.8543 |
_version_ | 1783511061243101184 |
---|---|
author | Nicastri, Emanuele Petrosillo, Nicola Ascoli Bartoli, Tommaso Lepore, Luciana Mondi, Annalisa Palmieri, Fabrizio D’Offizi, Gianpiero Marchioni, Luisa Murachelli, Silvia Ippolito, Giuseppe Antinori, Andrea |
author_facet | Nicastri, Emanuele Petrosillo, Nicola Ascoli Bartoli, Tommaso Lepore, Luciana Mondi, Annalisa Palmieri, Fabrizio D’Offizi, Gianpiero Marchioni, Luisa Murachelli, Silvia Ippolito, Giuseppe Antinori, Andrea |
author_sort | Nicastri, Emanuele |
collection | PubMed |
description | On January 9 2020, the World Health Organization (WHO) declared the identification, by Chinese Health authorities, of a novel coronavirus, further classified as SARS-CoV-2 responsible of a disease (COVID-19) ranging from asymptomatic cases to severe respiratory involvement. On March 9 2020, WHO declared COVID-19 a global pandemic. Italy is the second most affected country by COVID-19 infection after China. The “L. Spallanzani” National Institute for the Infectious Diseases, IRCCS, Rome, Italy, has been the first Italian hospital to admit and manage patients affected by COVID-19. Hereby, we show our recommendations for the management of COVID-19 patients, based on very limited clinical evidences; they should be considered as expert opinions, which may be modified according to newly produced literature data. |
format | Online Article Text |
id | pubmed-7097833 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | PAGEPress Publications, Pavia, Italy |
record_format | MEDLINE/PubMed |
spelling | pubmed-70978332020-03-26 National Institute for the Infectious Diseases “L. Spallanzani”, IRCCS. Recommendations for COVID-19 clinical management Nicastri, Emanuele Petrosillo, Nicola Ascoli Bartoli, Tommaso Lepore, Luciana Mondi, Annalisa Palmieri, Fabrizio D’Offizi, Gianpiero Marchioni, Luisa Murachelli, Silvia Ippolito, Giuseppe Antinori, Andrea Infect Dis Rep Expert Opinion On January 9 2020, the World Health Organization (WHO) declared the identification, by Chinese Health authorities, of a novel coronavirus, further classified as SARS-CoV-2 responsible of a disease (COVID-19) ranging from asymptomatic cases to severe respiratory involvement. On March 9 2020, WHO declared COVID-19 a global pandemic. Italy is the second most affected country by COVID-19 infection after China. The “L. Spallanzani” National Institute for the Infectious Diseases, IRCCS, Rome, Italy, has been the first Italian hospital to admit and manage patients affected by COVID-19. Hereby, we show our recommendations for the management of COVID-19 patients, based on very limited clinical evidences; they should be considered as expert opinions, which may be modified according to newly produced literature data. PAGEPress Publications, Pavia, Italy 2020-03-16 /pmc/articles/PMC7097833/ /pubmed/32218915 http://dx.doi.org/10.4081/idr.2020.8543 Text en ©Copyright: the Author(s), 2020 http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Expert Opinion Nicastri, Emanuele Petrosillo, Nicola Ascoli Bartoli, Tommaso Lepore, Luciana Mondi, Annalisa Palmieri, Fabrizio D’Offizi, Gianpiero Marchioni, Luisa Murachelli, Silvia Ippolito, Giuseppe Antinori, Andrea National Institute for the Infectious Diseases “L. Spallanzani”, IRCCS. Recommendations for COVID-19 clinical management |
title | National Institute for the Infectious Diseases “L.
Spallanzani”, IRCCS. Recommendations for COVID-19 clinical
management |
title_full | National Institute for the Infectious Diseases “L.
Spallanzani”, IRCCS. Recommendations for COVID-19 clinical
management |
title_fullStr | National Institute for the Infectious Diseases “L.
Spallanzani”, IRCCS. Recommendations for COVID-19 clinical
management |
title_full_unstemmed | National Institute for the Infectious Diseases “L.
Spallanzani”, IRCCS. Recommendations for COVID-19 clinical
management |
title_short | National Institute for the Infectious Diseases “L.
Spallanzani”, IRCCS. Recommendations for COVID-19 clinical
management |
title_sort | national institute for the infectious diseases “l.
spallanzani”, irccs. recommendations for covid-19 clinical
management |
topic | Expert Opinion |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7097833/ https://www.ncbi.nlm.nih.gov/pubmed/32218915 http://dx.doi.org/10.4081/idr.2020.8543 |
work_keys_str_mv | AT nicastriemanuele nationalinstitutefortheinfectiousdiseaseslspallanzaniirccsrecommendationsforcovid19clinicalmanagement AT petrosillonicola nationalinstitutefortheinfectiousdiseaseslspallanzaniirccsrecommendationsforcovid19clinicalmanagement AT ascolibartolitommaso nationalinstitutefortheinfectiousdiseaseslspallanzaniirccsrecommendationsforcovid19clinicalmanagement AT leporeluciana nationalinstitutefortheinfectiousdiseaseslspallanzaniirccsrecommendationsforcovid19clinicalmanagement AT mondiannalisa nationalinstitutefortheinfectiousdiseaseslspallanzaniirccsrecommendationsforcovid19clinicalmanagement AT palmierifabrizio nationalinstitutefortheinfectiousdiseaseslspallanzaniirccsrecommendationsforcovid19clinicalmanagement AT doffizigianpiero nationalinstitutefortheinfectiousdiseaseslspallanzaniirccsrecommendationsforcovid19clinicalmanagement AT marchioniluisa nationalinstitutefortheinfectiousdiseaseslspallanzaniirccsrecommendationsforcovid19clinicalmanagement AT murachellisilvia nationalinstitutefortheinfectiousdiseaseslspallanzaniirccsrecommendationsforcovid19clinicalmanagement AT ippolitogiuseppe nationalinstitutefortheinfectiousdiseaseslspallanzaniirccsrecommendationsforcovid19clinicalmanagement AT antinoriandrea nationalinstitutefortheinfectiousdiseaseslspallanzaniirccsrecommendationsforcovid19clinicalmanagement |